Literature DB >> 11927573

Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10.

Yaqiong Lin1, William C Hwang, Ravi Basavappa.   

Abstract

Cell cycle progression is controlled at several different junctures by the targeted destruction of cell cycle regulatory proteins. These carefully orchestrated events include the destruction of the securin protein to permit entry into anaphase, and the destruction of cyclin B to permit exit from mitosis. These destruction events are mediated by the ubiquitin/proteasome system. The human ubiquitin-conjugating enzyme, UbcH10, is an essential mediator of the mitotic destruction events. We report here the 1.95-A crystal structure of a mutant UbcH10, in which the active site cysteine has been replaced with a serine. Functional analysis indicates that the mutant is active in accepting ubiquitin, although not as efficiently as wild-type. Examination of the crystal structure reveals that the NH2-terminal extension in UbcH10 is disordered and that a conserved 3(10)-helix places a lysine residue near the active site. Analysis of relevant mutants demonstrates that for ubiquitin-adduct formation the presence or absence of the NH2-terminal extension has little effect, whereas the lysine residue near the active site has significant effect. The structure provides additional insight into UbcH10 function including possible sites of interaction with the anaphase promoting complex/cyclosome and the disposition of a putative destruction box motif in the structure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927573     DOI: 10.1074/jbc.M109398200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Degradation of some polyubiquitinated proteins requires an intrinsic proteasomal binding element in the substrates.

Authors:  Minglian Zhao; Nan-Yan Zhang; Ashley Zurawel; Kirk C Hansen; Chang-Wei Liu
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

2.  Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex.

Authors:  Lingyan Jin; Adam Williamson; Sudeep Banerjee; Isabelle Philipp; Michael Rape
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

3.  Distinct activation of an E2 ubiquitin-conjugating enzyme by its cognate E3 ligases.

Authors:  Itamar Cohen; Reuven Wiener; Yuval Reiss; Tommer Ravid
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 4.  Structural basis of generic versus specific E2-RING E3 interactions in protein ubiquitination.

Authors:  Mehmet Gundogdu; Helen Walden
Journal:  Protein Sci       Date:  2019-08-23       Impact factor: 6.725

5.  RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex.

Authors:  Nicholas G Brown; Ryan VanderLinden; Edmond R Watson; Renping Qiao; Christy R R Grace; Masaya Yamaguchi; Florian Weissmann; Jeremiah J Frye; Prakash Dube; Shein Ei Cho; Marcelo L Actis; Patrick Rodrigues; Naoaki Fujii; Jan-Michael Peters; Holger Stark; Brenda A Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

6.  Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.

Authors:  Jules Lin; Duna A Raoof; Zhuwen Wang; Mu-Yen Lin; Dafydd G Thomas; Joel K Greenson; Thomas J Giordano; Mark B Orringer; Andrew C Chang; David G Beer; Lin Lin
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

7.  A monoclonal antibody against a potential cancer biomarker, human ubiquitin-conjugating enzyme E2.

Authors:  Hongyan Du; Ligang Jie; Weiwen Xu; Yingsong Wu; Tiancai Liu; Ming Li
Journal:  Hybridoma (Larchmt)       Date:  2012-06

8.  Enzyme E2 from Chinese white shrimp inhibits replication of white spot syndrome virus and ubiquitinates its RING domain proteins.

Authors:  An-Jing Chen; Shuai Wang; Xiao-Fan Zhao; Xiao-Qiang Yu; Jin-Xing Wang
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

9.  Association of clinicopathological features with UbcH10 expression in colorectal cancer.

Authors:  Shimin Chen; Yingjian Chen; Chengjin Hu; Hongbiao Jing; Yongcheng Cao; Xianxi Liu
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-25       Impact factor: 4.553

Review 10.  Diversity of degradation signals in the ubiquitin-proteasome system.

Authors:  Tommer Ravid; Mark Hochstrasser
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.